This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Re: Just a theoretical question - what will be the best for bone metastases?
More conjecture additions to this, add another to the list you started: Dasatinib (Sprycel) in phase II/III now, it does build bone density(already known about), is already approved by FDA use for Leukemia patients. The trials now are for PCa useage, so you might be able to get it now under off label use (insurance won't cover it) or maybe under compasionate useage guidelines (aka Dr. Mark Moyad approach for obtaining)
Maybe estrogenic drugs, Dr. Myers points out in PCRI 2011 video, that patients using such for like 18 months, have bone density of 20-30 year people (his words). Plus such estrogenics can kill some hrpca in patients, Journal of Urology Nov, 2003 article as one reference.
